Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$423M |
| 2 |
Mettler-Toledo International
MTD
|
+$421M |
| 3 |
Capital One
COF
|
+$383M |
| 4 |
L3Harris
LHX
|
+$325M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.83B |
| 2 |
Microsoft
MSFT
|
+$1.62B |
| 3 |
Apple
AAPL
|
+$1.56B |
| 4 |
NVIDIA
NVDA
|
+$1.36B |
| 5 |
Costco
COST
|
+$731M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.97% |
| 2 | Financials | 13.28% |
| 3 | Healthcare | 9.87% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
PDS Biotechnology
PDSB
$13.3M
| $39K | ﹤0.01% |
29,293
| – | – |
|
|
CODX
3977
Co-Diagnostics
CODX
$5.49M
| $38.4K | ﹤0.01% |
4,569
| – | – |
|
3978
Denison Mines
DNN
$2.97B
| $35.2K | ﹤0.01% |
19,362
+1
| +0% | +$2 |
|
3979
GrafTech
EAF
$207M
| $34.8K | ﹤0.01% |
3,581
-56,412
| -94% | -$499K |
|
3980
Vera Bradley
VRA
$95M
| $32.2K | ﹤0.01% |
14,559
-53,189
| -79% | -$110K |
|
3981
Senseonics Holdings Inc
SENS
$410M
| $31.6K | ﹤0.01% |
3,316
+278
| +9% | +$3.24K |
|
3982
GoPro
GPRO
$117M
| $29.8K | ﹤0.01% |
39,360
-337,340
| -90% | -$219K |
|
3983
Ondas Inc
ONDS
$5.07B
| $29.4K | ﹤0.01% |
+15,305
| New | +$17.1K |
|
3984
IRIDEX
IRIX
$14.6M
| $27.8K | ﹤0.01% |
31,540
| – | – |
|
|
APLT
3985
DELISTED
Applied Therapeutics
APLT
| $24.7K | ﹤0.01% |
79,418
-237,037
| -75% | -$91.7K |
|
3986
Ocugen
OCGN
$461M
| $24.2K | ﹤0.01% |
24,920
-562,567
| -96% | -$467K |
|
3987
SCYNEXIS
SCYX
$49.2M
| $23.7K | ﹤0.01% |
4,382
| – | – |
|
3988
Baytex Energy
BTE
$2.99B
| $23.6K | ﹤0.01% |
13,201
-2,043
| -13% | -$3.57K |
|
3989
VolitionRx Ltd
VNRX
$7.59M
| $23.3K | ﹤0.01% |
1,530
| – | – |
|
3990
LiveOne
LVO
$57.3M
| $22.2K | ﹤0.01% |
2,936
-13,368
| -82% | -$99.4K |
|
3991
CEMIG Preferred Shares
CIG
$5.58B
| $22K | ﹤0.01% |
11,216
| – | – |
|
3992
Destination XL Group
DXLG
$33.3M
| $21.4K | ﹤0.01% |
19,250
-135,361
| -88% | -$148K |
|
3993
Immunic
IMUX
$229M
| $21.2K | ﹤0.01% |
3,046
-132
| -4% | -$1.21K |
|
|
MRSN
3994
DELISTED
Mersana Therapeutics
MRSN
| $19.7K | ﹤0.01% |
2,663
-11,185
| -81% | -$98.3K |
|
|
FLNA
3995
Filana Therapeutics
FLNA
$45.6M
| $19.3K | ﹤0.01% |
10,663
-99,995
| -90% | -$178K |
|
3996
Ovid Therapeutics
OVID
$521M
| $19K | ﹤0.01% |
57,697
-108,066
| -65% | -$32.6K |
|
3997
Pliant Therapeutics
PLRX
$66.3M
| $18.6K | ﹤0.01% |
16,035
-156,990
| -91% | -$222K |
|
3998
Lexicon Pharmaceuticals
LXRX
$1.05B
| $18.1K | ﹤0.01% |
19,124
-290,995
| -94% | -$189K |
|
3999
Caribou Biosciences
CRBU
$163M
| $17.7K | ﹤0.01% |
14,013
-210,373
| -94% | -$207K |
|
4000
Playboy Inc
PLBY
$150M
| $17.1K | ﹤0.01% |
10,546
| – | – |
|
Similar funds
Bank of New York Mellon's Q2 2025 Portfolio in Review
As of Q2 2025, Bank of New York Mellon held 4,353 positions worth $529B, up 4.8% from $505B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon withdrew a net $22.6B in Q2 2025, closing 217 positions and reducing 1,932 holdings. Its most notable exit was Discover Financial Services, an estimated $274M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Bank of New York Mellon opened a new position in JPMorgan Hedged Equity Laddered Overlay ETF worth $93.7M.
- Bank of New York Mellon's largest Q2 2025 buy was JPMorgan Hedged Equity Laddered Overlay ETF: 1,498,016 shares worth $93.7M.
- Bank of New York Mellon added most to Idexx Laboratories in Q2 2025, an estimated $423M increase.
- Bank of New York Mellon's biggest Q2 2025 reduction was Alphabet (Google) Class C, cutting an estimated $1.83B.
- Bank of New York Mellon fully exited Discover Financial Services in Q2 2025, selling an estimated $274M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $529B portfolio in Q2 2025.
- Bank of New York Mellon opened 243 new positions and closed 217 in Q2 2025.
- Bank of New York Mellon's portfolio value rose 4.8% quarter-over-quarter to $529B.
Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.